[Purpose]To analyze potential disasters and emergencies in Shanxi Provincial Cancer Hospital,and provide data support for strengthening emergency management in specialized cancer hospitals.[Methods]Based on the Kaiser model,factors potentially affecting hospital operations were comprehensively listed,and an initial index system was constructed from 4 dimensions:nat-ural disasters,technical accidents,personnel injuries,and hazards of dangerous goods.Through expert scoring,weight assignment,screening,and terminology revision,an evaluation system comprising 4 first-level indicators and 34 second-level indicators was developed.Questionnaire surveys were conducted among all hospital staff,yielding 236 valid responses in 2020 and 430 in 2024.Indicators such as the probability of occurrence and severity of consequences for each haz-ard event were analyzed.Combining indicator weights,relevant risk values for each hazard event were calculated,ranked,and compared across the two years to identify areas for emergency man-agement improvement.[Results]From the first-level indicator dimension,the average risk values of natural disasters ranked the first in both 2020 and 2024 evaluations,with personnel injury risks ranking the second,while technical accidents and dangerous goods hazards were relatively lower.In terms of secondary indicators,the top three disaster risk events in 2020 were epidemic out-break(20.39％),earthquake(19.26％),and violent attack on medical staff(18.61％),while in 2024,the top three were epidemic outbreak(15.65％),earthquake(13.86％),and elevator failure(12.27％).Risk event data comparison showed that epidemic outbreaks consistently ranked the first;violent attacks on medical staff decreased from 18.61％in 2020 to 11.66％in 2024,occupational expo-sure of medical staff from 18.03％to 11.51％,in-hospital patient falls/plummeting from 17.05％to 11.28％,and drug supply shortage from 15.22％to 9.97％,all with significant declines.Although the risk value of elevator failure decreased by 26.4％,its ranking rose from 7th in 2020 to 3rd in 2024.[Conclusion]The hospital should continuously optimize emergency plans,such as replac-ing aging elevators,increasing cybersecurity budgets,and introducing third-party mediation plat-forms,to further reduce risks and advance the Safe Hospital Initiative.

[Purpose]To analyze potential disasters and emergencies in Shanxi Provincial Cancer Hospital,and provide data support for strengthening emergency management in specialized cancer hospitals.[Methods]Based on the Kaiser model,factors potentially affecting hospital operations were comprehensively listed,and an initial index system was constructed from 4 dimensions:nat-ural disasters,technical accidents,personnel injuries,and hazards of dangerous goods.Through expert scoring,weight assignment,screening,and terminology revision,an evaluation system comprising 4 first-level indicators and 34 second-level indicators was developed.Questionnaire surveys were conducted among all hospital staff,yielding 236 valid responses in 2020 and 430 in 2024.Indicators such as the probability of occurrence and severity of consequences for each haz-ard event were analyzed.Combining indicator weights,relevant risk values for each hazard event were calculated,ranked,and compared across the two years to identify areas for emergency man-agement improvement.[Results]From the first-level indicator dimension,the average risk values of natural disasters ranked the first in both 2020 and 2024 evaluations,with personnel injury risks ranking the second,while technical accidents and dangerous goods hazards were relatively lower.In terms of secondary indicators,the top three disaster risk events in 2020 were epidemic out-break(20.39％),earthquake(19.26％),and violent attack on medical staff(18.61％),while in 2024,the top three were epidemic outbreak(15.65％),earthquake(13.86％),and elevator failure(12.27％).Risk event data comparison showed that epidemic outbreaks consistently ranked the first;violent attacks on medical staff decreased from 18.61％in 2020 to 11.66％in 2024,occupational expo-sure of medical staff from 18.03％to 11.51％,in-hospital patient falls/plummeting from 17.05％to 11.28％,and drug supply shortage from 15.22％to 9.97％,all with significant declines.Although the risk value of elevator failure decreased by 26.4％,its ranking rose from 7th in 2020 to 3rd in 2024.[Conclusion]The hospital should continuously optimize emergency plans,such as replac-ing aging elevators,increasing cybersecurity budgets,and introducing third-party mediation plat-forms,to further reduce risks and advance the Safe Hospital Initiative.

BACKGROUND/AIMS: Probiotics are expected to confer benefits on patients with constipation, but how probiotics act on constipated patients with variable stool consistencies remains unclear. We investigated the effect of Lactobacillus casei strain Shirota (LcS) on constipation-related symptoms, especially stool consistency, of constipated patients. METHODS: Constipated patients meeting the Rome III criteria were divided into 3 groups according to the Bristol Stool Form Scale (BSFS): hard (hard stool [HS], BSFS < 3), normal (normal stool [NS], ≤ 3 BSFS ≤ 4), and soft (soft stool [SS], 4 < BSFS ≤ 5) stools. Subjects in each group consumed a probiotic beverage containing 1010 colony-forming units of LcS daily for 28 days. RESULTS: LcS intervention significantly alleviated constipation-related symptoms and increased defecation frequency in all subjects. Four weeks of LcS supplementation softened the hard stools in HS, hardened the soft stools in SS, and did not alter the ideal stool consistency in NS. The short-chain fatty acid (SCFA) concentrations were highest in SS, followed by NS and HS. LcS intervention increased the stool SCFA levels in HS but reduced or did not alter the levels in NS and SS. LcS intervention increased the Pseudobutyrivibrio and Roseburia abundances in HS and decreased the Pseudobutyrivibrio abundance in SS. CONCLUSIONS: LcS supplementation improved the constipation-related symptoms in constipated subjects. Differences in baseline stool consistency could result in different anti-constipation effects of LcS intervention. LcS balanced the stool consistency—softened the HS and hardened the SS. These effects could be associated with modulation of the gut microbiota and SCFA production.
Beverages ; China ; Constipation ; Defecation ; Fatty Acids, Volatile ; Gastrointestinal Microbiome ; Humans ; Lactobacillus casei ; Lactobacillus ; Probiotics ; Stem Cells

Objective To evaluate the effects of sevoflurane on β-amyloid (Aβ)-induced cognitive dysfunction and oxidative stress response of hippocampal tissues in rats.Methods Ninety-six male adlut SpragueDawley rats,weighing 250-300 g,were randomly divided into 4 groups (n =24 each) using a random number table:control group (group C) ; group Aβ ; 1.3 ％ sevoflurane group (group S1) and 2.6 ％ sevoflurane group (group S2).The animals were anesthetized with intraperitoneal.10％ chloral hydrate 350 mg/kg.Cognitive dysfunction was induced by injecting Aβ1-40 2 μ1 into the bilateral hippocampi in Aβ,S1 and S2 groups.The equal volume of normal saline was given in group C.At 22 days after injection,C and Aβ groups were exposed to 30％ oxygen for 4 h,and S1 and S2 groups inhaled 1.3 ％ and 2.6 ％ sevoflurane,respectively,for 4 h.Eight rats were chosen at days 1,3 and 7 after exposure and cognitive function was assessed by Morris water maze test.The swimming speed,escape latency and exploration time at the original platform quadrant were recorded.The rats were then sacrificed after the end of the behavioral test and blood samples were taken for determination of serum S100β protein concentration.Hippocampi were immediately isolated and the homogenate was prepared for determination of superoxide dismutase (SOD) activity and malondialdehyde (MDA) content.Results Compared with group C,the escape latency was significantly prolonged and exploration time at the original platform quadrant was shortened,the serum S100β protein concentration and MDA content were increased,and SOD activity was decreased at each time point in group Aβ (P ＜ 0.05).There were no significant differences in the variables mentioned above between Aβ and S1 groups (P ＞ 0.05).The escape latency was significantly prolonged and the exploration time at the original platform quadrant was shortened,the serum S100β protein concentration and MDA content were increased,and SOD activity was decreased at each time point in group S2 as compared with Aβ and S1 groups (P ＜ 0.05).There was no significant difference in the swimining speed among the 4 groups (P ＞ 0.05).Conclusion Inhalation of 2.6 ％ sevoflurane for 4 h can aggravate the cognitive dysfunction induced by Aβ in rats and aggravation of oxidative stress response may be involved in the mechanism.

Objective To analyze clinical outcomes of the spouse donor kidney transplantation for evaluating the security.Methods Sixty-three cases of living-renal transplantation were divided into two groups, spouse donor group (12 cases) and the other related donor group (53 cases). Twelve cases of spouse-donor(SD)renal transplantation were summarized, that were compared with the nospouse transplantation cases of the other living-related renal transplantation in the same period, which were similar in basic conditions and in immunosuppressant scheme. The observational parameters included average hospitalization time, rate of acute renal necrosis, acute rejection incidence within 1 year, serum creatinine at 7 d, 30 d and 1 year after transplantation.Results The recipient age of the 2 groups was (39±3)years and (37±3)years(P=0.05), dialysis time was (4.7±3.2)months and (4.4±2.9)months(P=0.78), the average hospitalization time was (20.9±8.3)d and (23.0±7.8)d(P=0.41). There was no significant difference between the spouse donor group and the no spouse related donor group. The acute rejection incidence within 1 year was 33.3%(4/12) in spouse group and 3. 9%(2/51) in the other related group, there was significant difference between the 2 groups(P＜0.05). The rate of acute renal necrosis was 16.7%(2/12) in spouse group and 3.9%(2/15)in no spouse related group, there was no significant different between the 2 groups(P＞0.05).SCr was (206.47±47.22)μmol/L and (163. 75±25.91)μmol/L in spouse group at post-operation 7 d and 30 d, and was (142.79±89.42)μmol/L and (119. 99±15.03)μmol/L in no spouse group. There was significant difference between the groups(P=0.02, P=0.00). One year after operation, SCr was (133. 40±6. 11)μmol/L in spouse group and (121. 00±34.12)μmol/L in no spouse group,there was no significant difference between the 2 groups (P=0.25).Conclusions Preoperative comprehensive assessment of the spouse donors and recipients renal transplantation is the guarantee for the success.Short-term outcomes of spouse donor renal transplantation is ideal, but rate of acute rejection within 1 year is higher than that of the other living-relative donor kidney transplantation, which dose not influence the long-time survival of spouse recipients.

Objective To analyze the clinical outcomes and evaluate the safety of living related live donors in kidney transplantation.Methods One hundre and thirty-two cases of living related donors were studied retrospectively for psychological and physiological parameters. The parameters including life quality, urinalysis, serum biochemistry tests, glomerular filtration rate (GFR) and endogenous creatinine clearance rate (CCr) were analyzed.Results There was no significant difference between living related donors and normal people in the aspect of life quality. In living related donors,SCr was (78.33±15.94)μmol/L before operation and was (108.49±19.88)μmol/L at 7 days postoperation, P＜0.05. SCr was (112.47±20. 38)μmol/L at 6 months post-operation. There was no significant difference in SCr levels between 7 days and 6 months post-operation (P=0. 109). CCr was (95.80±20.92)ml/min in pre-operation and was (57.36±14. 92)ml/min at 7 days post-operation,P＜0.05. CCr was (65. 49±8. 25) ml/min at 6 months post-operation. There was no significant difference in CCr between 7 days and 6 months post-operation.The pre-operative total GFR was(74.08±18.51)ml/min. Of which, the right kidney GFR was (38.43±10.33)ml/min. The residual right kidney GFR was (56. 49±13. 01 ) ml/min 6 months after operation, which decreased 17. 59 ml/min (23.8%) compared with pre-operative total GFR (P＜0.05) and increased 18. 06 ml/min (47.0%) compared to the pre-operative right kidney GFR. Surgical complications included 1 case of splenectomy, 1 case of descending colon rupture and 5 cases of wound fat liquefactions.Conclusion Pre-operatively systemic psychological and physiological evaluation on living related donors, detailed consent consultation, standardized operating techniques, careful perioperative management and strict follow-up can improve the safety of living related donors.

OBJECTIVE:To discuss the way for clinical pharmacists to carry out pharmaceutical care.METHODS:We summarized the content,method and experiences of carrying out pharmaceutical care based on our clinical practice in Cardiology department.RESULTS & CONCLUSION:To provide all-round high quality pharmaceutical care for patients,clinical pharmacists should improve their own qualities by continuous learning knowledge and theories related to their own profession as well as improving their practical skills.

OBJECTIVE:To investigate the application situation and tendency of antihypertensive drugs in our hospital. METHODS: By a retrospective study,a total of 952 prescriptions of outpatients with hypertension were sampled from our hospital from Nov. 18 to Dec. 17 in 2007 for statistical analysis regarding the utilization of antihypertensive drugs,the treatment regimens,sales amount,DDDs and DDC,etc. RESULTS: The antihypertensive drugs were mainly used in single or two kinds concomitantly. Calcium-channel blocker (CCB) and angiotensin receptor Ⅱ binders(ARB) took the lead,accounting for 30.67% and 28.45%,respectively. Leading the first three places on the list of DDDs were Telmisartan,Amlodipine and Benidipine,and leading the first three places on the list of sales amount were Telmisartan,Valsartan and Amlodipine. CONCLUSION:The use of antihypertensive drugs in our hospital conforms to China Guidelines on Prevention and Management of Hypertension and the drug use criteria recommended by WHO.

OBJECTIVE:To evaluate the bioequivalence of two preparations of gemfibrozil.METHODS:A single oral dose of gemfibrozil enteric capsule(test preparation)and capsule(reference preparation)was given to20volunteers in an open ran?domized crossover way to study the pharmacokinetics and relative bioavailability.The plasma gemfibrozil concentrations were determined by HPLC method.RESULTS:The pharmacokinetic parameters of test and reference preparations were as follows:T max ,(2.4?0.6)h and(2.3?0.7)h;C max ,(21.8?7.3)?g/ml and(23.7?5.9)?g/ml;T 1/2 ,(2.0?0.4)h and(2.0?0.5)h;AUC 0～12 ,(68.1?13.7)(?g?h)/ml and(68.9?17.4)(?g?h)/ml;AUC 0～∞ (69.7?13.9)(?g?h)/ml and(70.6?17.8)(?g?h)/ml respectively.The relative bioavailability of test preparation was(100.8?15.0)%.The result of statistical analysis on above parameters showed that there was no significant difference between two preparations.CONCLUSION:The two prepa?rations were bioequivalent.

OBJECTIVE:A HPLC method has been developed to determine the concentration of isoniazid in plasma.METH_ODS:The Eclipse XDB-C18 column was used as fix phase and acetonitrile-0.05mol/L ammonium dihydrogen phosphate as mo_bile phase,detection wavelength was 280nm.The plasma sample was injected directly for determination after being deproteinized with 10% trichloroacetic acid and reacted with cinnamaldehyde and abstracted with ether.RESULTS:Good linear relationship was shown from 0.10 to 12.0?g/ml and the averge recovery of isoniazid was 95%～105%.CONCLUSION:The method is rapid,sensitive and is rarely interfered so it can be used in study of pharmacokinetics of isoniazid.